Barely Significant
← all excerpts

An Open-Label, Pilot Trial of HRG80™ Red Ginseng in Chronic Fatigue Syndrome, Fibromyalgia, and Post-Viral Fatigue.

Pharmaceuticals (Basel) · 2021 · PMC8777686 · PMID 35056100

1
hedged sentence
closest p
boldest claim

The sentences

highly significantno p-value reported
This is further supported by comparisons between those who took 1 tablet and 1 capsule per day in the subgroup of improvers, which did not reveal any significant differences, indicating that most of the highly significant improvement can be obtained by taking a single tablet of 100 mg of the HRG80 Red Ginseng combined with the gamma-cyclodextrin daily (see Table 6 ; additional supporting data are available on request).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.